Tvardi Therapeutics has a total of 51 patents globally, out of which 9 have been granted. Of these 51 patents, more than 96% patents are active. The United States of America is where Tvardi Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Tvardi Therapeutics.
Tvardi Therapeutics was founded in 2017. Tvardi Therapeutics is a privately held biotechnology company in the clinical stage of operation. The company creates and markets medications to treat fibrotic disorders, various malignancies, and chronic inflammation.
Do read about some of the most popular patents of Tvardi Therapeutics which have been covered by us in this article and also you can find Tvardi Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tvardi Therapeutics patent portfolio.
How many patents does Tvardi Therapeutics have?
Tvardi Therapeutics has a total of 51 patents globally. These patents belong to 9 unique patent families. Out of 51 patents, 49 patents are active.
How Many Patents did Tvardi Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Tvardi Therapeutics Applications Filed | Tvardi Therapeutics Patents Granted |
2023 | 4 | 1 |
2022 | 6 | 5 |
2021 | 14 | 3 |
2020 | 10 | – |
2019 | 17 | – |
How many Tvardi Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Tvardi Therapeutics File in Different Countries?
Countries in which Tvardi Therapeutics Filed Patents
Country | Patent |
United States Of America | 6 |
Hong Kong (S.A.R.) | 4 |
Europe | 4 |
Pakistan | 3 |
Canada | 3 |
Singapore | 2 |
Australia | 2 |
Mexico | 2 |
Brazil | 2 |
India | 2 |
China | 1 |
Poland | 1 |
Philippines | 1 |
Indonesia | 1 |
Spain | 1 |
Israel | 1 |
Hungary | 1 |
Argentina | 1 |
Austria | 1 |
Italy | 1 |
Portugal | 1 |
Japan | 1 |
Taiwan | 1 |
Denmark | 1 |
Uruguay | 1 |
Norway | 1 |
New Zealand | 1 |
Where are Research Centers of Tvardi Therapeutics Patents Located?
What Percentage of Tvardi Therapeutics US Patent Applications Were Granted?
Tvardi Therapeutics (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100%.
Below are the key stats of Tvardi Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Tvardi Therapeutics?
Law Firm | Total Applications | Success Rate |
Goodwin Procter Llp | 4 | 100% |
Norton Rose Fulbright Us Llp | 1 | 0% |
What are Tvardi Therapeutics key innovation segments?
What Technologies are Covered by Tvardi Therapeutics?
The chart below distributes patents filed by Tvardi Therapeutics